{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:09:57Z","timestamp":1788487797099,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T00:00:00Z","timestamp":1795219200000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD030363-01A1"],"award-info":[{"award-number":["1S10OD030363-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006151","name":"Basic Energy Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022789","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jid.2025.04.030","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T19:06:32Z","timestamp":1747422392000},"page":"3206-3209.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Jak1 Inhibition Is Sufficient for Treatment of Granuloma Annulare"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2458-9991","authenticated-orcid":false,"given":"Muhammad H.","family":"Junejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okeroghene","family":"Rufin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget E.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Rosenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0975-4071","authenticated-orcid":false,"given":"William","family":"Damsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.04.030_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/bjd\/ljac004","article-title":"Patient perspectives on the lived experience of granuloma annulare","volume":"188","author":"Clark","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.04.030_bib2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/ijd.16998","article-title":"Retrospective assessment of immunologic and histologic heterogeneity in granuloma annulare by cytokine staining","volume":"63","author":"Hwang","year":"2024","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2025.04.030_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41592-021-01274-5","article-title":"Systematic investigation of cytokine signaling activity at the tissue and single-cell levels","volume":"18","author":"Jiang","year":"2021","journal-title":"Nat Methods"},{"key":"10.1016\/j.jid.2025.04.030_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2024.2313090","article-title":"Oral abrocitinib in the treatment of granuloma annulare: a case report","volume":"35","author":"Liu","year":"2024","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jid.2025.04.030_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaad.2015.09.015","article-title":"Treatment of recalcitrant granuloma annulare (GA) with adalimumab: a single-center, observational study","volume":"74","author":"Min","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.04.030_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaad.2019.12.028","article-title":"Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways","volume":"83","author":"Min","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.04.030_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdcr.2024.05.030","article-title":"Ruxolitinib cream for the treatment of granuloma annulare","volume":"50","author":"Piontkowski","year":"2024","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jid.2025.04.030_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jdcr.2023.01.027","article-title":"A case of generalized granuloma annulare treated with upadacitinib","volume":"34","author":"Slater","year":"2023","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jid.2025.04.030_bib9","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jaci.2020.10.012","article-title":"Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib","volume":"147","author":"Wang","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.04.030_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/120347540100500202","article-title":"Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases","volume":"5","author":"Chren","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jid.2025.04.030_bib11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jaad.2019.05.098","article-title":"Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare","volume":"82","author":"Damsky","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.04.030_bib12","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41592-021-01274-5","article-title":"Systematic investigation of cytokine signaling activity at the tissue and single-cell levels","volume":"18","author":"Jiang","year":"2021","journal-title":"Nat Methods"},{"key":"10.1016\/j.jid.2025.04.030_bib13","doi-asserted-by":"crossref","first-page":"215914","DOI":"10.1016\/j.canlet.2022.215914","article-title":"The mitotic regulator RCC2 promotes glucose metabolism through BACH1-dependent transcriptional upregulation of hexokinase II in glioma","volume":"549","author":"Liu","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jid.2025.04.030_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jamadermatol.2013.60","article-title":"Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis","volume":"149","author":"Rosenbach","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.04.030_bib15","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jaci.2020.10.012","article-title":"Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib","volume":"147","author":"Wang","year":"2021","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25004841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25004841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:25:35Z","timestamp":1778473535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25004841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0022202X25004841"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.04.030","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Jak1 Inhibition Is Sufficient for Treatment of Granuloma Annulare","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}